Global Pre-filled Flush Syringes Market - 2023-2030

Global Pre-filled Flush Syringes Market - 2023-2030

Global Pre-filled Flush Syringes Market reached US$ XX billion in 2022 and is expected to reach US$ XX million by 2030 growing at a CAGR of XX% during the forecast period 2023-2030.

Pre-filled Saline flush syringes and heparin flush syringes are the two types of pre-filled flush syringes. A saline flush is a mixture of salt and water that is compatible with the body's fluids and tissues. It is used to push any residual medication or fluid through the IV line and into your vein. This keeps the peripheral intravenous line clean and reduces the risk of infection or occlusion.

The use of pre-filled saline syringes significantly reduced peripheral venous catheter failure and increased catheter dwell time. Thus, it is important to reinforce the use of pre-filled syringes for flushing to reduce the incidence of peripheral venous catheter failure.

Market Dynamics

Increasing demand for pre-filled flush syringes

The increasing prevalence of optical disorders acts as a significant driver for market growth. Contact lenses are thin, clear plastic disks that can be worn in the eye to improve vision. Therapeutic contact lenses are employed to treat various optical disorders like myopia, hyperopia, and astigmatism.

For instance, in May 2023, Becton, Dickinson and Company expanded customer availability of an all-in-one prefilled flush syringe with an integrated disinfection unit designed to reinforce compliance with infection prevention guidelines and simplify nursing workflow.

Additionally, in March 2022, the Food and Drug Administration (FDA) provided recommendations to healthcare personnel regarding the current shortage of prefilled 0.9% sodium chloride intravenous flush syringes due to an increase in demand during the COVID-19 public health emergency and vendor supply chain challenges.

Furthermore, significant growth drivers such as the rising prevalence of chronic diseases, and new product launches are expected to drive the market in the forecast period.

Complications associated with flush syringes

Pre-filled flush syringes are common medical devices used to clear intravenous lines. However, flush syringes can introduce air embolisms into a vein, which can lead to heart attacks, strokes, and respiratory failure. Also, the contaminated syringes have been linked to serious bacterial infections in patients

Segment Analysis

The global pre-filled flush syringes market is segmented based on product type, material, volume, distribution channel, and region.

The pre-filled saline syringes segment accounted for approximately 45.6% of the market share

The pre-filled saline syringes segment is expected to hold the largest market share over the period forecast. It helps to prevent IV catheters from becoming blocked and also to help remove any medication that is left at the catheter site.

For instance, the AMSafe Pre-Filled Normal Saline Flush Syringe contains 0.9% Sodium Chloride, USP saline per mL sterile water. These single-use prefilled syringes help reduce medication errors and contamination risks associated with multi-dose vials. It also improves clinician efficiency and workflow by eliminating the steps and time involved in the manual preparation of saline syringes.

Additionally, PolyFlush by Polymed offers safety over manually prepared flush syringes by reducing the risk of catheter-related bloodstream infections. It improves the workflow efficiency and eliminates the risk of needle stick injuries. Hence, due to the above factors, the segment is expected to hold the largest market share.

Geographical Analysis

North America is expected to hold a significant position in the global pre-filled flush syringes market share

The global pre-filled flush syringes market is segmented into North America, Europe, Asia Pacific, South America, Middle East, and Africa.

North America has maintained a significant market proportion due to factors such as the rising prevalence of chronic disorders, and increasing healthcare expenditure, this trend is anticipated to continue throughout the forecast period.

For instance, according to Centers for Disease Control and Prevention estimates, six out of ten persons in the United States presently suffer from a chronic illness like diabetes, heart disease, or cancer. Heart disease and cancer alone account for about 38% of all deaths in the United States, making chronic diseases one of the main causes of death. Hence the demand for prefilled flush syringes increases as it plays a major role in drug administration.

Additionally, out of every 5 Canadians aged 20 years or older, 3 have a chronic disease and 4 are at risk of developing a chronic condition. Thus, the above factors help to drive the region’s growth.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global pre-filled flush syringes market. The onset of the pandemic in early 2020 led to widespread lockdowns and restrictions, impacting regular diagnoses, treatment, product launches, and consultations worldwide. With the outbreak of the pandemic, many pharmaceutical or medical device manufacturing units faced labor shortages and were unable to travel to work due to lockdown restrictions. Therefore, owing to the above factors, the pre-filled flush syringes market is expected to be moderately affected over the forecast period.

Market Segmentation

By Product Type
• Pre-filled Saline Syringes
• Pre-filled Heparin Flush Syringes

By Material
• Plastic-based
• Glass-based

By Volume
• 3 mL
• 5 mL
• 10 mL

By Distribution Channel
• Retail pharmacy
• Hospital pharmacy
• Online pharmacy

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Competitive Landscape

The major global players in the market include Becton Dickinson and Company, B Braun Medical Inc., Poly Medicure Ltd., Halyard Health, Nipro Corporation, Cardinal Health Inc., Pentaferte Italia, Merit Pharmaceuticals, KDL Corp, Optimum Medical Limited among others.

Key Developments
• In April 2022, Delpharm invested €28M in a sterile line to manufacture prefilled syringes.
• In October 2022, Global contract development and manufacturing organisation (CDMO) Recipharm, invested in a new high speed filling line for pre-filled syringes and cartridges at its facility in Wasserburg.

Why Purchase the Report?
• To visualize the global pre-filled flush syringes market segmentation based on product type, material, volume, distribution channel, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global pre-filled flush syringes market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global pre-filled flush syringes market report would provide approximately 61 tables, 69 figures, and 185 Pages.

Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies